Nexus Surgical and Medicare Ltd
NSE: BSE: 538874
₹20.49
(2.40%)
Mon, 25 May 2026, 04:53 pm
Market Cap104.29M
PE Ratio19.18
Dividend0
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Nexus Surgical and Medicare Analysis
dividend
Pros
Cons
- Unable to evaluate Nexus Commodities and Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Nexus Commodities and Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
Pros
- Nexus Commodities and Technologies has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 9.6% each year.
- Nexus Commodities and Technologies has sufficient cash runway for more than 3 years based on current free cash flow.
- Debt is covered by short term assets, assets are 2.1x debt.
- Nexus Commodities and Technologies has no long term commitments.
- Nexus Commodities and Technologies's level of debt (5.2%) compared to net worth is satisfactory (less than 40%).
Cons
- Nexus Commodities and Technologies's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Operating cash flow is negative therefore debt is not well covered.
- High level of physical assets or inventory.
management
Pros
- The tenure for the Nexus Commodities and Technologies board of directors is about average.
- Rupesh's remuneration is lower than average for companies of similar size in India.
- Rupesh's compensation has been consistent with company performance over the past year, both up more than 20%.
Cons
misc
Pros
Cons
- Nexus Commodities and Technologies is not covered by any analysts.
- Nexus Commodities and Technologies has significant price volatility in the past 3 months.
- BSE:538874 has not traded for 21 days.
past
Pros
Cons
- Unable to compare Nexus Commodities and Technologies's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Nexus Commodities and Technologies does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Nexus Commodities and Technologies has efficiently used its assets last year compared to the IN Capital Markets industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Nexus Commodities and Technologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Nexus Commodities and Technologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Nexus Commodities and Technologies's 1-year growth to the IN Capital Markets industry average as it is not currently profitable.
value
Pros
- 538874 outperformed the Capital Markets industry which returned -21% over the past year.
- 538874 matched the India Market (-14.5%) over the past year.
Cons
- Nexus Commodities and Technologies is overvalued based on assets compared to the IN Capital Markets industry average.
- Nexus Commodities and Technologies is loss making, we can't compare its value to the IN Capital Markets industry average.
- Nexus Commodities and Technologies is loss making, we can't compare the value of its earnings to the India market.
- BSE:538874 is flat (0%) underperforming the Capital Markets industry which returned 8.7% over the past month.
- BSE:538874 is flat (0%) underperforming the market in India which returned 8% over the past month.